CN108771082A - A kind of complex prebiotics solid beverage and preparation method thereof - Google Patents
A kind of complex prebiotics solid beverage and preparation method thereof Download PDFInfo
- Publication number
- CN108771082A CN108771082A CN201810973052.5A CN201810973052A CN108771082A CN 108771082 A CN108771082 A CN 108771082A CN 201810973052 A CN201810973052 A CN 201810973052A CN 108771082 A CN108771082 A CN 108771082A
- Authority
- CN
- China
- Prior art keywords
- solid beverage
- complex prebiotics
- parts
- inulin
- prebiotics solid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 45
- 235000013406 prebiotics Nutrition 0.000 title claims abstract description 45
- 239000007787 solid Substances 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims abstract description 51
- 239000000843 powder Substances 0.000 claims abstract description 39
- 229920001202 Inulin Polymers 0.000 claims abstract description 33
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 33
- 229940029339 inulin Drugs 0.000 claims abstract description 33
- 235000010355 mannitol Nutrition 0.000 claims abstract description 25
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims abstract description 23
- 150000003271 galactooligosaccharides Chemical class 0.000 claims abstract description 23
- 240000000851 Vaccinium corymbosum Species 0.000 claims abstract description 18
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims abstract description 18
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims abstract description 18
- 235000021014 blueberries Nutrition 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 239000000796 flavoring agent Substances 0.000 claims abstract description 7
- 240000001717 Vaccinium macrocarpon Species 0.000 claims description 15
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 claims description 15
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 claims description 15
- 235000004634 cranberry Nutrition 0.000 claims description 15
- VDTNNGKXZGSZIP-UHFFFAOYSA-N carbutamide Chemical compound CCCCNC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 VDTNNGKXZGSZIP-UHFFFAOYSA-N 0.000 claims description 13
- 239000013078 crystal Substances 0.000 claims description 13
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 6
- 229930091371 Fructose Natural products 0.000 claims description 5
- 229960002737 fructose Drugs 0.000 claims description 5
- 235000013355 food flavoring agent Nutrition 0.000 claims description 4
- 239000005715 Fructose Substances 0.000 claims description 3
- 206010012735 Diarrhoea Diseases 0.000 abstract description 16
- 230000000968 intestinal effect Effects 0.000 abstract description 16
- 206010010774 Constipation Diseases 0.000 abstract description 15
- 208000002551 irritable bowel syndrome Diseases 0.000 abstract description 15
- 208000024891 symptom Diseases 0.000 abstract description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 8
- 208000035475 disorder Diseases 0.000 abstract description 7
- 230000002906 microbiologic effect Effects 0.000 abstract description 5
- 239000000126 substance Substances 0.000 abstract description 5
- 230000001151 other effect Effects 0.000 abstract description 4
- 244000297179 Syringa vulgaris Species 0.000 abstract description 3
- 235000004338 Syringa vulgaris Nutrition 0.000 abstract description 3
- 235000019634 flavors Nutrition 0.000 abstract description 3
- 239000012535 impurity Substances 0.000 abstract description 3
- 239000000725 suspension Substances 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 241000186000 Bifidobacterium Species 0.000 description 11
- 230000013872 defecation Effects 0.000 description 11
- 230000000694 effects Effects 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 6
- 241000186660 Lactobacillus Species 0.000 description 6
- 239000007640 basal medium Substances 0.000 description 6
- 229940039696 lactobacillus Drugs 0.000 description 6
- 229920001542 oligosaccharide Polymers 0.000 description 6
- 150000002482 oligosaccharides Chemical class 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000003814 drug Substances 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 206010000060 Abdominal distension Diseases 0.000 description 4
- GUBGYTABKSRVRQ-PICCSMPSSA-N D-Maltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 4
- 206010022998 Irritability Diseases 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 241000186016 Bifidobacterium bifidum Species 0.000 description 2
- 241001608472 Bifidobacterium longum Species 0.000 description 2
- 241000186604 Lactobacillus reuteri Species 0.000 description 2
- 241000227653 Lycopersicon Species 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 229930014669 anthocyanidin Natural products 0.000 description 2
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 2
- 235000008758 anthocyanidins Nutrition 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 2
- 229940009291 bifidobacterium longum Drugs 0.000 description 2
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 206010016766 flatulence Diseases 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940001882 lactobacillus reuteri Drugs 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000186018 Bifidobacterium adolescentis Species 0.000 description 1
- 241000186012 Bifidobacterium breve Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000017228 Gastrointestinal motility disease Diseases 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241000186605 Lactobacillus paracasei Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical group 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- -1 oligofructose Chemical class 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000004089 psychotropic agent Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 125000000185 sucrose group Chemical group 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention discloses a kind of complex prebiotics solid beverage and preparation method thereof, which includes following raw material:Oligofructose, Oligomeric manna sugar, galactooligosaccharide, inulin and blueberry powder.The complex prebiotics solid beverage of the present invention is lilac, in uniform powder, with the distinctive smell of this product, flavour, free from extraneous odour is visible by naked eyes exogenous impurity, it rushes molten rear in uniform suspension, its physical and chemical index and microbiological indicator etc. are met the requirements of the standard, and to the efficient up to 90% or more of irritable bowel syndrome crowd, had and are quickly adjusted intestinal microecology balance, function of intestinal canal disorder symptoms such as relief of constipation, diarrhea and other effects, securely and reliably;Preparation method is simple, and production cost is low, implementation easy to operate.
Description
Technical field
The present invention relates to solid beverage technical fields, and in particular to a kind of complex prebiotics solid beverage and its preparation side
Method.
Background technology
Irritable bowel syndrome is a kind of function of intestinal canal disorders, shows as lasting or intermittent attack abdominal pain and distension,
Diarrhea or constipation etc..Person between twenty and fifty are group of people at high risks, and it is all to induce irritable bowel syndrome that mental element, improper diet, body, which catch cold,
Factor.Irritable bowel syndrome can be divided into diarrhea predominance type, constipation leading type and alternating diarrhea and constipation according to symptom difference.
The reason of causing irritable bowel syndrome may be gastrointestinal motility disorder, visceral paresthesia, enteron aisle by bacterium, virus or and
The infection of examination causes enterogastritis or function of intestinal canal disorder or since caused by mental element, there are certain psychology by patient
Obstacle, as operating pressure is big, anxiety, depression etc. can aggravate the burden of stomach.
The treatment of existing irritable bowel syndrome is mainly drug administration as gastrointestinal antispasmodic medicine, gastrointestinal tract dynamia correlation medicine
Object, elimination gastrointestinal tract flatulence drug, beneficial bacteria of intestinal tract etc., can also take psychotropic agent, the overweight pressure of reduction of patient is loosened
Mood if patient suffers from serious constipation, can take cathartic, help patient's defecation in short term not in anxiety.But drug administration
Will produce drug accordance with tolerance, and drug it is all more or less there is certain toxic side effect, be unfavorable for health.Also there is use
Food therapy alleviates irritable bowel syndrome, but food therapy therapeutic effect is bad, and the progress for the treatment of is slow.Therefore, it is badly in need of exploitation
A kind of food of energy rapid recovery irritable bowel syndrome malaise symptoms, and accordance with tolerance is small, securely and reliably, has no toxic side effect.
Invention content
For problems of the prior art, the purpose of the present invention is to provide a kind of complex prebiotics solid beverage and
Preparation method, the complex prebiotics solid beverage are lilac, are in uniform powder, have the distinctive smell of this product, flavour,
Free from extraneous odour is visible by naked eyes exogenous impurity, and it is in afterwards uniform suspension to rush molten, and physical and chemical index and microbiological indicator etc. meet
Standard requirement has to the efficient up to 90% or more of irritable bowel syndrome crowd and quickly adjusts intestinal microecology balance, alleviate
Function of intestinal canal disorder symptoms such as constipation, diarrhea and other effects, securely and reliably;Preparation method is simple, and production cost is low, reality easy to operate
It applies.
In order to achieve the above object, the present invention is achieved by the following scheme.
(1) a kind of complex prebiotics solid beverage, including following raw material:Oligofructose, Oligomeric manna sugar, oligomeric gala
Sugar, inulin and blueberry powder.
Preferably, the raw material further includes Cranberry powder.
Preferably, the raw material further includes flavoring agent.
Preferably, the flavoring agent is crystal diabetin.
Preferably, the dosage of the raw material is:2.5-3.5 parts of oligofructose, 12-16 parts of Oligomeric manna sugar, oligomeric gala
18-22 parts of 25-35 parts sugared, 18-22 parts of inulin, 10-14 parts of blueberry powder, 1-3 parts of Cranberry powder and crystal diabetin.
Preferably, the dosage of the raw material is:3.2 parts of oligofructose, 14.4 parts of Oligomeric manna sugar, galactooligosaccharide 30.4
Part, 20 parts of inulin, 12 parts of blueberry powder, 1 part of Cranberry powder and 19 parts of crystal diabetin.
(2) a kind of preparation method of complex prebiotics solid beverage, including following preparation process:By oligofructose, oligomeric
Mannose, galactooligosaccharide, inulin and blueberry powder are uniformly mixed to get complex prebiotics solid beverage.
Compared with prior art, beneficial effects of the present invention are:
The complex prebiotics solid beverage of gained of the invention is lilac, is in uniform powder, has the distinctive gas of this product
Taste, flavour, free from extraneous odour are visible by naked eyes exogenous impurity, rush molten rear in uniform suspension, physical and chemical index and microbiological indicator
Deng meeting the requirements of the standard.Complex prebiotics solid beverage irritable bowel syndrome crowd's is efficient up to 90% or more;Wherein, right
The effective percentage of diarrhea-type irritability syndrome crowd reaches the effective percentage of the crowd of constipation-predominant of irritable bowel syndrome up to 90% or more
95% or more, have and adjusts intestinal microecology balance, function of intestinal canal disorder symptoms such as relief of constipation, diarrhea and other effects.
Specific implementation mode
Embodiment of the present invention is described in detail below in conjunction with embodiment, but those skilled in the art will
It will be appreciated that the following example is merely to illustrate the present invention, and it is not construed as limiting the scope of the invention.
Embodiment 1
A kind of preparation method of complex prebiotics solid beverage, including following preparation process:
By oligofructose 3.20%, Oligomeric manna sugar 14.40%, galactooligosaccharide 30.40%, inulin 20.00%, blueberry
Powder 12%, Cranberry powder 1% and 19% crystal diabetin are uniformly mixed to get complex prebiotics solid beverage.
Embodiment 2
A kind of preparation method of complex prebiotics solid beverage, including following preparation process:
By oligofructose 2.50%, Oligomeric manna sugar 12.00%, galactooligosaccharide 35.00%, inulin 20.00%, blueberry
Powder 10.5%, Cranberry powder 2% and 18% crystal diabetin are uniformly mixed to get complex prebiotics solid beverage.
Embodiment 3
A kind of preparation method of complex prebiotics solid beverage, including following preparation process:
By oligofructose 3.50%, Oligomeric manna sugar 16.00%, galactooligosaccharide 25.00%, inulin 22.00%, blueberry
Powder 10.5%, Cranberry powder 3% and 20% crystal diabetin are uniformly mixed to get complex prebiotics solid beverage.
Embodiment 4
A kind of preparation method of complex prebiotics solid beverage, including following preparation process:
By oligofructose 3.00%, Oligomeric manna sugar 14.00%, galactooligosaccharide 30.00%, inulin 18.00%, blueberry
Powder 14%, Cranberry powder 1% and 20% crystal diabetin are uniformly mixed to get complex prebiotics solid beverage.
Embodiment 5
A kind of preparation method of complex prebiotics solid beverage, including following preparation process:
By oligofructose 3.20%, Oligomeric manna sugar 14.40%, galactooligosaccharide 32.40%, inulin 20.00%, blueberry
Powder 10%, Cranberry powder 2% and 18% crystal diabetin are uniformly mixed to get complex prebiotics solid beverage.
Embodiment 6
A kind of preparation method of complex prebiotics solid beverage, including following preparation process:
By oligofructose 3.00%, Oligomeric manna sugar 14.00%, galactooligosaccharide 30.00%, inulin 18.00%, blueberry
Powder 10%, Cranberry powder 3% and 22% crystal diabetin are uniformly mixed to get complex prebiotics solid beverage.
In above example, Oligomeric manna sugar (MOS) is to pass through β-Isosorbide-5-Nitrae or β -1,3 glycosidic bonds by 2-10 monosaccharide molecule
The oligosaccharide being formed by connecting.It can effectively facilitate the proliferation of the beneficial bacteria of intestinal tract such as Bifidobacterium, lactobacillus, inhibit harmful bacteria
Growth reduces intestinal pH, improves immunity etc..
Oligofructose is that 1~3 molecule is combined on sucrose residue by acting on for fructose-transferring enzyme using sucrose as raw material
Fructose and the oligosaccharide mixture obtained.Oligofructose is the activation and proliferation factor of Bifidobacterium, and Bifidobacterium is once in human body
It is proliferated, whole intestines effect can be generated.
Galactooligosaccharide is adjusting intestinal flora, raising immunity etc. with good life as functional prebiotics
Manage effect.For crowds such as overweight people, the elderlys, galactooligosaccharide is improving diarrhea, is adjusting intestinal flora balance, promotion mineral
Matter absorption or raising immunity etc. have significant health efficacy.
Inulin is by D-Fructose through linear straight chain polysaccharide made of β (1 → 2) glycosidic bond links, the normal Portugal with there are one in end
Grape saccharide residue, the degree of polymerization (DP) are 2~60, and the inulin of wherein average degree of polymerization DP≤9 is also known as short chain inulin, from natural plants
The inulin of middle extraction contains long-chain and short chain simultaneously.Inulin is a kind of natural water-soluble dietary fiber, can hardly be by hydrochloric acid in gastric juice
Hydrolysis and digestion, are only utilized in colon by beneficial microbe, so as to improve intestinal environment.The proliferation degree of Bifidobacterium depends on
The quantity of initial Bifidobacterium in human body large intestine, it is bright using cultivation effect after inulin when initial bifidobacteria is reduced
It is aobvious, when the quantity of initial Bifidobacterium is more, it is not obvious using effect after inulin.Secondly, it can enhance stomach and intestine after taking in inulin
Road is wriggled, and functions of intestines and stomach is improved, and increases digestion and appetite, improves immunity of organisms.
For providing anthocyanidin and assisting seasoning, there is anthocyanidin anti-oxidant, enhancing human body to exempt from for blueberry powder and Cranberry powder
The multi-efficiencies such as epidemic disease power, prevention of cardiovascular disease, anticancer, anti-inflammatory, skin care and beauty;And blueberry powder and Cranberry powder can
With the energy balanced with oligofructose, Oligomeric manna sugar, galactooligosaccharide and inulin comprehensive function, enhancing adjusting intestinal microecology
Power, the function of intestinal canal disorder symptoms such as relief of constipation, diarrhea.Crystal diabetin makes the complex prebiotics solid of the present invention for seasoning
The mouthfeel of beverage is more preferably.
To the oligofructose in complex prebiotics solid beverage in implementing above, Oligomeric manna sugar, galactooligosaccharide, inulin
Organoleptic indicator, physical and chemical index and the microbiological indicator of equal raw materials are detected respectively, and specific testing result is as shown in table 1-4.
The testing result of 1 oligofructose of table
The testing result of 2 Oligomeric manna sugar of table
The testing result of 3 galactooligosaccharide of table
The testing result of 4 inulin of table
By table 1-4 it is found that oligofructose, Oligomeric manna sugar in the complex prebiotics solid beverage of the present invention, oligomeric half
Organoleptic indicator, physical and chemical index and microbiological indicator of the raw materials such as lactose, inulin etc. are met the requirements of the standard, and feedstock property is stablized,
Property using the complex prebiotics solid beverage of its preparation is stablized, more securely and reliably.
Using the different oligosaccharide such as oligofructose, Oligomeric manna sugar, galactooligosaccharide, inulin to Bifidobacterium and lactobacillus
In-vitro multiplication effect carries out analysis of experiments, specific as follows:
1) test method
The configuration of 1.1 culture mediums
Strain activation and culture base:MRS meat soups, BBL fluid nutrient mediums;
Bifidobacterium basal medium:Peptone 1.5%, yeast powder 0.2%, soluble starch 0.05%, half Guang ammonia of L-
Acid hydrochloride 0.05%, tomato soak juice 40%, and liver soaks powder 0.2%, NaCl 0.5%, Tween 80 0.1%, pH 6.8 ± 0.2;
Tomato soaks juice and prepares:Chopping is weighed after fresh tomato is cleaned, and adds the distilled water of equivalent in 100 DEG C of water-baths
90min is stirred in heating, adjusts pH7.0;
Lactobacillus basal medium:Peptone 1%, powdered beef 1%, yeast powder 0.5%, sodium acetate 0.5%, ammonium citrate
0.2%, MgSO40.01%, KH2PO40.2%, MnSO40.005%, Tween 80 0.1%, pH 7.3 ± 0.2;
Count culture medium:MRS agar, BBL agar mediums.
1.2 activated spawn
Take the strain of -20 DEG C of glycerol tube liquid preservations of 0.5mL in anaerobism pipe (15mL/20mL) respectively, after mixing in
37 DEG C of stationary culture 14h measure viable count, are repeated twice rear spare.
The effect assessment of 1.3 different oligosaccharide in-vitro multiplication Bifidobacteriums and lactobacillus
Each seed liquor is seeded to according to 1% inoculum concentration in corresponding culture medium respectively, after mixing for 24 hours in 37 DEG C of cultures,
Zymotic fluid is taken to measure viable count, viable count, which measures, refers to GB 4789.35-2016《National food safety standard Food Microbiology
Lactic acid bacteria is examined to examine》.
Experimental group (oligosaccharide):1% seed liquor++ 2% Oligomeric manna sugar of basal medium/xylo-oligosaccharide/oligomeric fruit
Sugar/oligoisomaltose/stachyose/inulin/galactooligosaccharide;
Control group:1% seed liquor+basal medium;
Blank group:Basal medium ,+2% Oligomeric manna sugar of basal medium/xylo-oligosaccharide/oligofructose/oligomeric different wheat
Bud sugar/stachyose/inulin/galactooligosaccharide.
2) test result
Galactooligosaccharide and oligofructose can significantly be proliferated bifidobacterium breve;Galactooligosaccharide and inulin can significantly be proliferated dry
Lactobacillus paracasei;Inulin can significantly be proliferated lactobacillus reuteri;Oligofructose can significantly be proliferated bifidobacterium longum.
Oligomeric manna sugar can significantly be proliferated long and short, youth, bifidobacterium bifidum and acidophilus, cheese, lactobacillus reuteri;
And Oligomeric manna sugar can make bifidobacterium adolescentis viable count increase by 22.57%, bifidobacterium longum viable count increase by 10.17%, it is short
The number of active bifid bacteria increases by 12.07%, and bifidobacterium bifidum viable count increases by 14.8%, Roy this living preparation of lactobacillus number increase
10.7%, live lactobacillus acidophilus number increases by 15.6%, and the variation of Lactobacillus casei viable count dramatically increases 10.01% the most.And
Show that oligofructose, Oligomeric manna sugar, galactooligosaccharide, inulin have synergistic function by experimental study, can obviously carry
The viable count of high Bifidobacterium and lactobacillus;The blueberry powder of addition and Cranberry powder have the synergistic function of oligosaccharide simultaneously
There is booster action so that the complex prebiotics solid beverage of present invention gained, which has, preferably adjusts intestinal microecology balance, delays
Solve function of intestinal canal disorder symptoms such as constipation, diarrhea and other effects.
The eating method of the complex prebiotics solid beverage of gained of the invention is:The complex prebiotics solid beverage of 10g is
One packet, a daily packet, is added the water Instant Drinks of 150mL in often being wrapped when drinking.By the complex prebiotics obtained by above example
Solid beverage is used for the crowd with diarrhea-type irritability syndrome and constipation-predominant of irritable bowel syndrome and carries out clinical observation, as a result
Show the complex prebiotics solid beverage of gained of the invention to the efficient up to 90% or more of irritable bowel syndrome crowd;Wherein,
To the efficient up to 90% or more of 100 diarrhea-type irritability syndrome crowds;To the people of 100 constipation-predominant of irritable bowel syndrome
The effective percentage of group is below the clinical effectiveness of the part model case of complex prebiotics solid beverage of the present invention up to 95% or more:
1, diarrhea-type irritability syndrome:
Symptom:Abdominal pain, abdominal distension, duration or intermittent diarrhea, excrement amount is few, in the pasty state, containing a large amount of mucus etc..
Case 1
Mrs Li, 26 years old, intermittent diarrhea 3 years, frequent abdominal pain, diarrhea (daily defecation 3-4 times), excrement amount was few, is not molded
In the pasty state, malt sugar shape, remission after defecation;After taking the complex prebiotics solid beverage 3 days of the gained of embodiment 1, abdominal pain
Improve, excrement is molded to chunky shape, and malt sugar symptom improves, and defecation frequency is reduced.
Case 2
Mr. Zhao, 32 years old, persistent diarrhea 5 years ate maror or drinks more, belly flatulence, abdomen often occurs
Bitterly, persistent diarrhea (daily defecation 3-4 times) is not molded in malt sugar shape, and symptom mitigates after defecation;Through taking 2 gained of embodiment
Complex prebiotics solid beverage after 4 days, abdominal pain improves, and defecation frequency is reduced, and excrement malt sugar symptom improves, and just forms strip,
Exhaust improves.
2, constipation-predominant of irritable bowel syndrome:
Symptom:Difficult defecation, dry and hard excrement, amount is few, can not to the utmost feel with more mucus, defecation.
Case 3
Ms Zhang, 27 years old, intermittent constipation 1 year, frequent constipation, abdominal distension, difficult defecation (3 days not defecation), stool was compared
Dry, amount is few, always there is the feeling etc. of defecation not to the utmost;After taking the complex prebiotics solid beverage 3 days of the gained of embodiment 5, row
Just smooth, defecation frequency increases (1 day defecation 1 time), and feces volume increases, and fecal water increases, and abdominal distension improves, and intestines peristalsis sense increases
Add.
Case 4
Mrs Hui, 32 years old, constipation 2 years, constipation always, abdominal distension, big tripe just, difficult defecation (2-3 days not defecation), stool
Dry and hard, feces volume is few, and defecation is not to the utmost etc.;The complex prebiotics solid beverage of 1 gained of embodiment is taken after 3 days, defecation becomes smooth,
Defecation frequency increases (1 day defecation 1-2 times), and feces volume increases, and fecal water obviously increases, and abdominal distension improves, and exhaust number increases,
Intestines peristalsis sense enhances.
Although the present invention is described in detail with a general description of the specific embodiments in this specification,
But on the basis of the present invention, it can be made some modifications or improvements, this will be apparent to those skilled in the art.
Therefore, these modifications or improvements without departing from theon the basis of the spirit of the present invention, belong to claimed model
It encloses.
Claims (7)
1. a kind of complex prebiotics solid beverage, which is characterized in that including following raw material:It is oligofructose, Oligomeric manna sugar, oligomeric
Galactolipin, inulin and blueberry powder.
2. complex prebiotics solid beverage according to claim 1, which is characterized in that the raw material further includes Cranberry
Powder.
3. complex prebiotics solid beverage according to claim 2, which is characterized in that the raw material further includes flavoring agent.
4. complex prebiotics solid beverage according to claim 3, which is characterized in that the flavoring agent is crystal diabetin.
5. complex prebiotics solid beverage according to claim 4, which is characterized in that the dosage of the raw material is:It is oligomeric
2.5-3.5 parts of fructose, 12-16 parts of Oligomeric manna sugar, 25-35 parts of galactooligosaccharide, 18-22 parts of inulin, 10-14 parts of blueberry powder,
18-22 parts of 1-3 parts of Cranberry powder and crystal diabetin.
6. complex prebiotics solid beverage according to claim 5, which is characterized in that the dosage of the raw material is:It is oligomeric
3.2 parts of fructose, 14.4 parts of Oligomeric manna sugar, 30.4 parts of galactooligosaccharide, 20 parts of inulin, 12 parts of blueberry powder, 1 part of Cranberry powder and
19 parts of crystal diabetin.
7. a kind of preparation method of complex prebiotics solid beverage, which is characterized in that including following preparation process:By oligomeric fruit
Sugar, Oligomeric manna sugar, galactooligosaccharide, inulin and blueberry powder are uniformly mixed to get complex prebiotics solid beverage.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810973052.5A CN108771082A (en) | 2018-08-24 | 2018-08-24 | A kind of complex prebiotics solid beverage and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810973052.5A CN108771082A (en) | 2018-08-24 | 2018-08-24 | A kind of complex prebiotics solid beverage and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108771082A true CN108771082A (en) | 2018-11-09 |
Family
ID=64029494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810973052.5A Pending CN108771082A (en) | 2018-08-24 | 2018-08-24 | A kind of complex prebiotics solid beverage and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108771082A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109349489A (en) * | 2018-11-16 | 2019-02-19 | 西安源森生物科技有限公司 | A kind of solid beverage and preparation method thereof with function of delaying senility |
CN111387391A (en) * | 2020-04-27 | 2020-07-10 | 山东亿海鹏生经贸有限公司 | Production method of prebiotics electrolyte beverage |
CN112401100A (en) * | 2020-11-26 | 2021-02-26 | 恩施天天佳生物科技有限公司 | Mannose oligomer enzyme solid beverage and preparation method thereof |
CN113974043A (en) * | 2021-10-18 | 2022-01-28 | 山东星光首创生物科技有限公司 | Prebiotics solid beverage and preparation method thereof |
CN115299542A (en) * | 2022-07-14 | 2022-11-08 | 青岛博恩高科生物技术有限公司 | Solid beverage with functions of improving intestinal function and preventing and treating constipation and application thereof |
CN116649583A (en) * | 2023-06-21 | 2023-08-29 | 山东英贝健健康食品有限公司 | Prebiotic composition, beverage and preparation method thereof |
CN116869108A (en) * | 2023-08-18 | 2023-10-13 | 尚氏(广东)大数据服务有限公司 | Prebiotic solid beverage and preparation method thereof |
CN116869108B (en) * | 2023-08-18 | 2024-04-19 | 尚氏(广东)大数据服务有限公司 | Prebiotic solid beverage and preparation method thereof |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040037868A1 (en) * | 2002-08-20 | 2004-02-26 | Minich Deanna M. | Select prebiotics for use in weight attenuation message and method of communication |
WO2013067424A1 (en) * | 2011-11-06 | 2013-05-10 | Ssv Therapeutics, Llc | Formulations of concentrated prunes and prebiotics as laxatives and dietary supplements |
CN104188040A (en) * | 2014-08-18 | 2014-12-10 | 理想科技集团有限公司 | Complex probiotic solid health beverage and preparation method thereof |
CN104642870A (en) * | 2015-02-05 | 2015-05-27 | 骆奇 | Prebiotics composition |
CN105982009A (en) * | 2015-02-05 | 2016-10-05 | 骆奇 | Composition for regulating human body intestinal micro-ecology |
CN106605909A (en) * | 2016-08-01 | 2017-05-03 | 西安源森生物科技有限公司 | Composition capable of relaxing the bowels, expelling toxin and preventing constipation, as well as preparation method thereof |
CN106617091A (en) * | 2016-11-08 | 2017-05-10 | 广东正当年生物科技有限公司 | Probiotics and prebiotic compound preparation |
CN107467677A (en) * | 2017-08-22 | 2017-12-15 | 北京特食生物科技研究中心(有限合伙) | A kind of compound nutritional product for relaxing bowel, maintaining intestinal health and preparation method and application |
-
2018
- 2018-08-24 CN CN201810973052.5A patent/CN108771082A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040037868A1 (en) * | 2002-08-20 | 2004-02-26 | Minich Deanna M. | Select prebiotics for use in weight attenuation message and method of communication |
WO2013067424A1 (en) * | 2011-11-06 | 2013-05-10 | Ssv Therapeutics, Llc | Formulations of concentrated prunes and prebiotics as laxatives and dietary supplements |
CN104188040A (en) * | 2014-08-18 | 2014-12-10 | 理想科技集团有限公司 | Complex probiotic solid health beverage and preparation method thereof |
CN104642870A (en) * | 2015-02-05 | 2015-05-27 | 骆奇 | Prebiotics composition |
CN105982009A (en) * | 2015-02-05 | 2016-10-05 | 骆奇 | Composition for regulating human body intestinal micro-ecology |
CN106605909A (en) * | 2016-08-01 | 2017-05-03 | 西安源森生物科技有限公司 | Composition capable of relaxing the bowels, expelling toxin and preventing constipation, as well as preparation method thereof |
CN106617091A (en) * | 2016-11-08 | 2017-05-10 | 广东正当年生物科技有限公司 | Probiotics and prebiotic compound preparation |
CN107467677A (en) * | 2017-08-22 | 2017-12-15 | 北京特食生物科技研究中心(有限合伙) | A kind of compound nutritional product for relaxing bowel, maintaining intestinal health and preparation method and application |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109349489A (en) * | 2018-11-16 | 2019-02-19 | 西安源森生物科技有限公司 | A kind of solid beverage and preparation method thereof with function of delaying senility |
CN111387391A (en) * | 2020-04-27 | 2020-07-10 | 山东亿海鹏生经贸有限公司 | Production method of prebiotics electrolyte beverage |
CN112401100A (en) * | 2020-11-26 | 2021-02-26 | 恩施天天佳生物科技有限公司 | Mannose oligomer enzyme solid beverage and preparation method thereof |
CN113974043A (en) * | 2021-10-18 | 2022-01-28 | 山东星光首创生物科技有限公司 | Prebiotics solid beverage and preparation method thereof |
CN115299542A (en) * | 2022-07-14 | 2022-11-08 | 青岛博恩高科生物技术有限公司 | Solid beverage with functions of improving intestinal function and preventing and treating constipation and application thereof |
CN116649583A (en) * | 2023-06-21 | 2023-08-29 | 山东英贝健健康食品有限公司 | Prebiotic composition, beverage and preparation method thereof |
CN116869108A (en) * | 2023-08-18 | 2023-10-13 | 尚氏(广东)大数据服务有限公司 | Prebiotic solid beverage and preparation method thereof |
CN116869108B (en) * | 2023-08-18 | 2024-04-19 | 尚氏(广东)大数据服务有限公司 | Prebiotic solid beverage and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108771082A (en) | A kind of complex prebiotics solid beverage and preparation method thereof | |
Shoaib et al. | Inulin: Properties, health benefits and food applications | |
JP6144745B2 (en) | Composition containing alpha- (1,2) -branched alpha- (1,6) oligodextran and process for producing alpha- (1,2) -branched alpha- (1,6) oligodextran | |
CN105054040B (en) | A kind of composition of probiotics fermention ginseng and its preparation method and application | |
JP5498698B2 (en) | New uses of white jellyfish miscellaneous polysaccharides or their extracts | |
Nakata et al. | Inhibitory effects of laminaran and alginate on production of putrefactive compounds from soy protein by intestinal microbiota in vitro and in rats | |
CN104642870B (en) | A kind of prebiotic compositions | |
US20040086491A2 (en) | Probiotic/Prebiotic Composition and Delivery Method | |
JP2006522766A (en) | Symbiotic combination | |
PT1150577E (en) | Improved microbial preparations | |
KR20050115854A (en) | Composition containing β-glucan and constipation-relieving drug, immunopotentiator and skin moistening agent using the composition | |
Devi et al. | Preferential growth stimulation of probiotic bacteria by galactan exopolysaccharide from Weissella confusa KR780676 | |
CN111227261A (en) | Prebiotic composition and application thereof | |
CN109315769A (en) | It is a kind of for improving the composition and preparation method thereof of human body enteral environment | |
JP2020524177A (en) | Composition for preventing, improving or treating deterioration of intestinal function, which contains an enzymatic decomposition product or a bamboo shoot fermentation product as an active ingredient | |
CN112970990A (en) | Probiotic solid beverage with weight-losing and lipid-lowering effects and preparation process thereof | |
CN104886569A (en) | An active probiotic fermented drink and a preparation method thereof | |
TWI719549B (en) | Prebiotic composition for promoting growth of akkermansia muciniphila | |
KR100865075B1 (en) | Novel probiotic strain Lactobacillus sp. SM1 showes high cell adherence | |
CN107106479A (en) | Improve the composition of the cellulite outward appearance of skin | |
CN104886700A (en) | Probiotic fermented beverage and preparation method thereof | |
Mitsou et al. | Impact of a jelly containing short-chain fructo-oligosaccharides and Sideritis euboea extract on human faecal microbiota | |
CN105495150B (en) | Using cassia seed lactobacillus fermentation as the constipation improvement of effective ingredient, treatment or prevention composition and its manufacturing method | |
AU2020210564B2 (en) | A yeast product, and a composition comprising it, for use as a prebiotic agent | |
KR101808306B1 (en) | Lactobacillus casei strain for enhancing activity of improving or preventing constipation by fermenting Cassia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181109 |
|
RJ01 | Rejection of invention patent application after publication |